• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯硼酸功能化聚氨基糖苷作为一种有效的 CRISPR/Cas9 递送系统。

Phenylboronic acid-functionalized polyaminoglycoside as an effective CRISPR/Cas9 delivery system.

机构信息

Key Laboratory of Biomedical Materials of Natural Macromolecules (Beijing University of Chemical Technology), Ministry of Education, Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, China.

出版信息

Biomater Sci. 2021 Oct 26;9(21):7104-7114. doi: 10.1039/d1bm00185j.

DOI:10.1039/d1bm00185j
PMID:34704559
Abstract

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) gene editing technology is a promising approach for cancer therapy, and its application practice urgently requires a safe and effective gene carrier. In this work, we focus on the design of a phenylboronic acid (PBA)-functionalized, disulfide bonded branched polyaminoglycoside (SS-HPT-P) as a robust delivery vector of the CRISPR-Cas9 system. SS-HPT-P showed great tumor-targeting performance, reduction-responsive degradability, and gene transfection ability. The typical pCas9-surv (one CRISPR-Cas9 plasmid that targets and knocks out the survivin gene) delivery mediated by SS-HPT-P exhibited gene editing performance in the A549 cell line, confirming the feasibility of SS-HPT-P to effectively deliver the CRISPR-Cas9 system. SS-HPT-P/pCas9-surv could effectively inhibit the proliferation of tumor cells both and , suggesting the potential of PBA-functionalized nanocarriers for cancer gene therapy. The present work provides a promising approach for the treatment of malignant tumors.

摘要

簇状规律间隔短回文重复 (CRISPR)/CRISPR 相关蛋白 9 (Cas9) 基因编辑技术是癌症治疗的一种有前途的方法,其应用实践迫切需要安全有效的基因载体。在这项工作中,我们专注于设计一种苯硼酸 (PBA) 功能化、二硫键连接的支化聚氨基葡萄糖 (SS-HPT-P),作为 CRISPR-Cas9 系统的强大递送载体。SS-HPT-P 表现出出色的肿瘤靶向性能、还原响应性降解能力和基因转染能力。由 SS-HPT-P 介导的典型 pCas9-surv(一种靶向并敲除生存素基因的 CRISPR-Cas9 质粒)传递在 A549 细胞系中表现出基因编辑性能,证实了 SS-HPT-P 有效传递 CRISPR-Cas9 系统的可行性。SS-HPT-P/pCas9-surv 可有效抑制肿瘤细胞的增殖,表明 PBA 功能化纳米载体在癌症基因治疗中的潜力。本工作为恶性肿瘤的治疗提供了一种有前途的方法。

相似文献

1
Phenylboronic acid-functionalized polyaminoglycoside as an effective CRISPR/Cas9 delivery system.苯硼酸功能化聚氨基糖苷作为一种有效的 CRISPR/Cas9 递送系统。
Biomater Sci. 2021 Oct 26;9(21):7104-7114. doi: 10.1039/d1bm00185j.
2
Fluorinated Acid-Labile Branched Hydroxyl-Rich Nanosystems for Flexible and Robust Delivery of Plasmids.氟代酸敏感的支化型富含羟自由基的纳米系统,用于质粒的灵活和稳健的递送。
Small. 2018 Oct;14(42):e1803061. doi: 10.1002/smll.201803061. Epub 2018 Sep 20.
3
A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.一种多功能非病毒载体,用于递送 MTH1 靶向的 CRISPR/Cas9 系统,用于非小细胞肺癌治疗。
Acta Biomater. 2022 Nov;153:481-493. doi: 10.1016/j.actbio.2022.09.046. Epub 2022 Sep 24.
4
Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.通过调节苯硼酸衍生脂质纳米颗粒与细胞表面唾液酸的界面实现细胞选择性信使 RNA 传递和 CRISPR/Cas9 基因组编辑。
ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46585-46590. doi: 10.1021/acsami.9b17749. Epub 2019 Dec 9.
5
Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.通过超分子聚合物介导的 Cas9 核糖核蛋白递送来编辑突变 KRAS 基因组,用于结直肠癌治疗。
J Control Release. 2020 Jun 10;322:236-247. doi: 10.1016/j.jconrel.2020.03.015. Epub 2020 Mar 10.
6
[Research progress of CRISPR-Cas9 system for gene therapy].[用于基因治疗的CRISPR-Cas9系统的研究进展]
Sheng Wu Gong Cheng Xue Bao. 2016 Jul 25;32(7):861-869. doi: 10.13345/j.cjb.150542.
7
Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer.聚合物胶束纳米粒用于癌症中有效的 CRISPR/Cas9 基因组编辑。
Biomaterials. 2024 Sep;309:122573. doi: 10.1016/j.biomaterials.2024.122573. Epub 2024 Apr 17.
8
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
9
Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma.基于电荷反转纳米复合物的 CRISPR/Cas9 递药系统用于肝细胞癌中致癌基因的功能丧失编辑。
J Control Release. 2021 May 10;333:362-373. doi: 10.1016/j.jconrel.2021.03.030. Epub 2021 Mar 27.
10
[Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白9系统在干细胞研究中的应用进展
Zhonghua Shao Shang Za Zhi. 2018 Apr 20;34(4):253-256. doi: 10.3760/cma.j.issn.1009-2587.2018.04.013.

引用本文的文献

1
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications.用于临床应用中CRISPR-Cas9递送的精准靶向纳米颗粒
Nanomaterials (Basel). 2025 Apr 2;15(7):540. doi: 10.3390/nano15070540.
2
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing.探索用于治疗性基因组编辑的先进CRISPR递送技术。
Small Sci. 2024 Jul 25;4(10):2400192. doi: 10.1002/smsc.202400192. eCollection 2024 Oct.
3
Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics.
受聚合物生物材料启发的细胞表面调节用于新型抗癌治疗药物的研发。
Biomater Res. 2023 Jun 21;27(1):59. doi: 10.1186/s40824-023-00404-8.